(Q45390356)

14 December 2017

title

Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1). (English)

1 reference

14 December 2017

1 reference

5

Othmar G Engelhardt

1 reference

14 December 2017

Ruth Harvey

1

1 reference

14 December 2017

Jun X Wheeler

series ordinal

2

1 reference

14 December 2017

Chantal L Wallis

series ordinal

3

1 reference

14 December 2017

James S Robertson

series ordinal

4

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

14 December 2017

1 reference

14 December 2017

volume

26

1 reference

14 December 2017

issue

51

1 reference

14 December 2017

page(s)

6550-6554

1 reference

Update on avian influenza A (H5N1) virus infection in humans

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.050

Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.050

Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.050

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.050

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.050

An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Application for potency determinations of inactivated whole virus and subunit vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.050

Characterization of the protein content of a meningococcal outer membrane vesicle vaccine by polyacrylamide gel electrophoresis and mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.050

Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.050

Enhanced growth of seed viruses for H5N1 influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.050

10.1016/J.VACCINE.2008.09.050

7 January 2021

Identifiers

DOI

1 reference

14 December 2017

1 reference